LH 1
immunostimulant used in antitumor therapy; RN given refers to (3alpha,5alpha)-isomer
Also Known As:
3 alpha-N-(2-aminoethanoyl)amino-5 alpha-pregnan-20-one; LH-1; Pregnan-20-one, 3-((2-amino-1-hydroxyethyl)amino)-, (3alpha,5alpha)-
Networked: 12
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Balaji, K C:
1 article
(01/2020)
|
2. | Fung, Russell:
1 article
(01/2020)
|
3. | Gandhi, Gunjan Y:
1 article
(01/2020)
|
4. | Makary, Raafat:
1 article
(01/2020)
|
5. | Natter, Patrick E:
1 article
(01/2020)
|
6. | Grossmann, Mathis:
1 article
(01/2019)
|
7. | Hoermann, Rudolf:
1 article
(01/2019)
|
8. | Wong, Henry K:
1 article
(01/2019)
|
9. | Duan, Lingdi:
1 article
(11/2018)
|
10. | Fang, Haiyan:
1 article
(11/2018)
|
Related Diseases
1. | Hypogonadism (Hypergonadotropic Hypogonadism)
01/01/2019
- " Total testosterone was 3.0 nmol/L (0.6-21.3), and luteinizing hormone (LH) 1.2 mIU/L (<0.2-7.5), with 91% of cases demonstrating hypogonadotropic hypogonadism. " 01/01/2020
- " Hormonal testing noted possible secondary adrenal insufficiency (AM serum cortisol: 3.3 mcg/dL, ACTH: 8 pg/mL), secondary hypothyroidism (TSH: <0.01 mIU/L, FT4: 0.7 ng/dL), secondary hypogonadism (testosterone: 47 ng/dL, LH: 1.3 mIU/mL, and FSH: 2.3 mIU/mL), and elevated serum prolactin (prolactin: 56.8 ng/ml, normal: 4.0-15.2 ng/ml). "
|
2. | Body Weight (Weight, Body)
|
3. | Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
|
4. | Pulmonary Fibrosis (Fibrosing Alveolitis)
|
5. | Pituitary Neoplasms (Pituitary Adenoma)
|
|
Related Drugs and Biologics
Related Therapies and Procedures